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Infants are in negative iodine balance on current standard regimens of total parenteral 
nutrition, with a mean iodine intake of 3 μg/kg/day (150 ml/kg/day). The recommended 
enteral intake of iodine for preterm infants is 30 μg/kg/day. Gastrointestinal absorption of 
iodine is high, suggesting that parenteral intakes should approach enteral 
recommendations. 
 
 
Iodine is essential for synthesis of thyroid hormones, and thyroxine is necessary for brain 
development. Transient hypothyroxinaemia in preterm infants is characterised by postnatal 
reductions in serum levels of total thyroxine, free thyroxine, and triiodothyronine, with 
normal levels of thyroid stimulating hormone. Transient hypothyroxinaemia is present in 
most infants of < 30 weeks gestation and is characteristically associated with reductions in 
intelligence quotient scores but also increased risks of cerebral palsy. The cause of 
transient hypothyroxinaemia is not clear, with contributions from withdrawal of maternal-
placental thyroxine transfer, hypothalamic-pituitary-thyroid immaturity, developmental 
constraints on the synthesis and peripheral metabolism of iodothyronines, non-thyroidal 
illness, and iodine deficiency. 
An enteral intake of at least 30–40 mg iodine/kg/day is required to achieve a positive 
iodine balance in healthy preterm infants. Younger and sicker infants, 27–30 weeks 
gestation, can be in negative iodine balance for the first weeks, and 30 mg iodine/kg/day is 
the recommended enteral intake for extreme preterm infants.3 Increasing enteral intakes 
further to 40–50 mg iodine/kg/day in more mature preterm infants does not alter serum 
iodothyronine levels. Infants who were parenterally fed were excluded from all these 
studies. We now report iodine intakes and urinary iodine outputs in a cohort of infants of < 
30 weeks gestation who were initially parenterally fed. 
 
 
PATIENTS AND METHODS 
Thirteen consecutive inborn infants were recruited: male/female ratio, gestation mean, 
26.8 weeks (range 24–29); birth weight mean, 926 g (range 570–1260). All had intensive 
care support and survived at least 28 days. 
On day 1 of life all infants had parenteral dextrose/electrolyte/amino acid solution 
(Vaminolact; Fresenius Kabi, Runcorn, Cheshire, UK) with a phosphate supplement 
(Addiphos; Fresenius Kabi). On day 2, and thereafter, this solution was supplemented with 
water soluble vitamins (Solvito N; Fresenius Kabi) and trace elements (Peditrace; 
Fresenius Kabi). In tandem, a fat emulsion (Intralipid 20%; Fresenius Kabi) with added fat 
soluble vitamins (Vitlipid; Fresenius Kabi) was infused, initially at 8 ml/kg/day, increasing 
maximally to 18 ml/kg/day by day 5. Enteral feeds were started as hourly boluses, 0.5–1 
ml, increased as determined by the infants’ clinical condition, with reciprocal reductions in 
parenteral solutions infused. No infant progressed beyond hourly bolus feeds. 
A 24 hour iodine balance was calculated for each infant at days 1, 6, 13, and 27. The 
types and volumes of all enteral and parenteral fluids used were recorded, and the iodine 
contents determined. Urine volumes per 24 hours were collected, and an aliquot used for 
iodine estimations. No iodine-containing skin disinfectants were used. All iodine 
determinations were performed using the method described for serum but with minor 
modifications depending on the type of sample. 
The Tayside Medical Research ethics committee approved the study protocol. Informed 
written parental consent was obtained. 
 
RESULTS 
The volumes and energy intakes of parenteral and enteral feeding solutions were within 
the ranges expected for extreme preterm infants (table 1). 
Iodine intakes were calculated from contents of solutions used: dextrose/electrolyte/amino 
acid solution on day 1,mean 0.9 mg/dl (range 0.4–2.0), n = 11; on days 2–28, mean 1.6 
mg/dl (range 0.4–11.2), n = 37; fat emulsion, mean 4.1 mg/dl (range 1–10), n = 28; 
expressed breast milk, mean 10.1 mg/dl (range 4–28), n = 13; Cow and Gate Nutriprem 1, 
mean 20.2 mg/dl (range 15–24), n = 5; red blood cell concentrates, mean 7.1 mg/dl (range 
4–10), n = 10; fresh frozen plasma, 0.7 mg/dl, n = 1; Hepsal (CP Pharmaceuticals), mean 
3.45 mg/dl (range 0.8–10.4), n = 8; Abidec (Warner Lambert), 8 mg/dl, n = 1; 
benzylpenicillin (Biochemie Gmbh), mean 9.6 mg/dl, n = 5; caffeine (Tayside 
Pharmaceutical), mean 10.2 mg/dl, n = 6; ceftazidime (Glaxo Wellcome), 10 mg/dl, n = 1; 
dopamine (Abbott), 10 mg/dl, n = 1; frusemide (Martindale Pharmaceuticals), 7.5 mg/dl, n 
= 2; gentamicin (Hoechst Marion Roussel), 11.3 mg/dl, n = 4; indomethacin (Merck Sharp 
and Dohme), 10 mg/dl, n = 1; insulin (Novo Nordisk), 9 mg/dl, n = 1; Sytron (Link 
Pharmaceuticals), 1 mg/dl, n = 1; midazolam (Roche Products Ltd), 13 mg/dl, n = 1; 
vancomycin (Faulding), 7 mg/dl, n = 1. 
Mean iodine intake (mg/kg/day) increased with postnatal age, as did mean urinary iodine 
output (table 2), paralleled by increased enteral nutritional intakes as parenteral nutrition 
volumes decreased (table 1). Parenteral nutrition supplied 100% of energy intake at day 1, 
70% at day 6, 58% at day 13, and 28% at day 27. All 13 infants were in negative iodine 
balance on day 1, and 12 remained in negative balance at day 6. By day 13, six infants 
were in negative balance, but by day 28 only three infants remained in negative balance 
(table 2). 
 
DISCUSSION 
The parenteral nutrition solutions used were made by the pharmacy from the component 
parts, according to the manufacturer’s recommendations. Although different batches of 
both dextrose/electrolyte/amino acid solution and fat emulsion were used, most had iodine 
contents within a limited range of values. The parenteral trace element additive was 
Peditrace solution, which contains potassium iodide. The manufacturer’s recommended 
dosage for infants and children weighing 15 kg or less, and 2 days old or older, is 1 
ml/kg/day of Peditrace parenteral solution, which contains 1.3 mg/ml potassium iodide 
equivalent to 1 mg iodide/kg/day. 
The recommended enteral intake of iodine for preterm infants based on balance studies is 
30 mg/kg/day. The main route of excretion of excess absorbed iodine is through urinary 
output. Stools were not collected for iodine content because a previous study had shown 
that faecal iodine outputs were relatively small, about 6% and 10% of intake for term and 
preterm infants respectively.4 Iodine absorption by the gastrointestinal tract is high, 
suggesting that there should be a near equivalence of iodine dosage, whether this is by 
the enteral or parenteral route. 
Iodine deficiency contributes to about 30% of the hypothyroxinaemia in enterally fed 
preterm infants of 27–30 weeks gestation.3 The percentage contribution of iodine 
deficiency to hypothyroxinaemia may be greater in our more immature infants who have a 
very low parenteral iodine supply. We are currently testing the following hypothesis. If 
extreme preterm infants are supplemented from the first day of life with parenteral iodine to 
recommended intakes (30 mg/kg/day), this will improve iodine balance and more 
importantly postnatal serum iodothyronine levels. 
 
 
 
Table 
1  
Types and volumes of enteral and parenteral nutrition fluids at balance days in 13 extreme preterm 
infants  
 Parenteral nutrition   Enteral nutrition   Total nutrition   
Postnatal 
age (days)        
ml/kg/day  kcal/kg/day  ml/kg/day  kcal/kg/day  ml/kg/day  kcal/kg/day  
1  79 (56–96)  31 (24–38)  –  –  79 (56–96)  31 (24–38)  
6  110 (7–173)  63 (3–104)  42 (0–189)  27 (0–122)  152 (95–209)  91 (53–125)  
13  98 (0–152)  51 (0–93)  56 (0–204)  37 (0–133)  154 (101–204)  88 (56–133)  
27  65 (0–185)  28 (0–104)  101 (0–196)  65 (0–147)  166 (31–196)  93 (39–147)  
Values are mean (range).       
 
 
 
Table 
2  
Iodine balances in 13 preterm infants during the first 27 days of life  
 Mean iodine intake (μg/kg/day)  Mean iodine intake (μg/day)  Mean iodine urine output (μg/day)  
Iodine balance (μg/day, +/-)  
Day 1  1.0 (0.6–1.7)  0.92 (0.6–2.0)  3.1 (1.3–7.8)  -2.19 (-0.4 to -2.8)  
Day 6  3.6 (0.5–9.4)  3.24 (0.6–8.2)  5.5 (1.8–8.1)  -2.3 (-0.9 to -4.8)  
Day 13  10.0 (1.5–33.4)  10.0 (1.2–39.4)  4.9 (1.6–13.6)  +5.5 (+35.4 to -1.1)  
Day 27  19.6 (1.5–38.0)  22.5 (1.5–49.6)  17.2 (4.0–36.8)  +3.3 (+14.1 to -2.4)  
Ranges are shown in parentheses. The iodine balance data (last column) were derived from the balances of the individual infants. It is NOT 
simply the difference between the mean intake (column 2) and mean output (column 3).  
 
